Assessing the safety and performance of LuxBoost intraocular lenses for cataract patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation aims to evaluate the safety and performance of bilateral implantation of LuxBoost intraocular lenses (IOLs) in patients with cataracts, comparing them to the LuxGood monofocal lens. The study involves participants aged 50 and over who are scheduled for posterior chamber IOL implantation. The LuxBoost IOL is a hydrophobic acrylic lens designed to enhance visual outcomes for patients with aphakia. Participants will undergo a series of examinations to assess the effectiveness and safety of the lens post-implantation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject aged 50 or over on the day of inclusion, presenting a
* bilateral cataract for which posterior chamber IOL implantation
* has been planned.
* Fit within the available IOL diopter range.
* Have had no previous refractive surgery.
* Regular corneal astigmatism \< 1 dioptre by an automatic
* keratometer (regularity measured by topographer).
* Availability, willingness, and sufficient cognitive awareness to
* comply with examination procedures.
* Ability to attend all study follow-ups.
* Signed informed consent.

Exclusion Criteria:

* Ocular surface disease potentially affecting study results
* Subjects suffering from diagnosed degenerative visual disorders
* Pre-existing ocular pathology
* Acute or chronic disease or illness that would increase risk or confound study results
* Axial lengths and keratometry such as the IOL spherical power is
* not in the range of 14 to 28 D
* Instability of keratometry or biometry measurements
* Amblyopia
* History of ocular trauma or any prior ocular surgery including refractive procedures
* Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens

Where it's running

• Clinique Honore Cave
  Montauban, France Recruiting
• West Ophta
  Rennes, France Recruiting

Study contacts

• Principal investigator: Vincent GUALINO — Clinique Honoré Cave 82000 Montauban
• Study coordinator: Ilham XHAARD
• Email: ilham.xhaard@cutting-edge.fr
• Phone: 620 050 651

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparison of a new trifocal IOL with PanOptix Pro IOL in cataract surgery

  This study tests whether the investigational trifocal IOL LPYWT0 works as well as the PanOptix Pro trifocal IOL in people with cataracts undergoing cataract surgery in both eyes.

  Recruiting Alcon Research · Sydney, New South Wales and 4 other locations · NCT07587138

• Clareon TruPlus IOLs in Bilateral Cataract Surgery

  This study tests Clareon TruPlus Monofocal IOLs to see how safe they are and how well they perform for people with both eyes affected by cataracts.

  Recruiting at 5 sites Alcon Research · Phoenix, Arizona and 4 other locations · NCT07502456

• Visual adaptation and quality of life after different IOL implantation options

  This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.

  Recruiting Sichuan Academy of Medical Sciences · Chengdu · NCT07740590

• Comparing two surgical methods for fixing intraocular lenses without capsular support

  This study is testing two different surgical methods to see which one works better for fixing eye lenses in patients who don't have the usual support from the eye's capsule.

  Recruiting Medical University of Vienna · Vienna · NCT06102109

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.